Pacific Biosciences
(PACB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 69,028 | 43,342 | 68,862 | 29,927 | 33,084 |
| Marketable Securities | 139,522 | 76,621 | 73,729 | 19,472 | 16,120 |
| Receivables | 11,806 | 11,346 | 7,325 | 15,266 | 9,966 |
| Inventories | 15,940 | 16,768 | 16,124 | 13,312 | 15,067 |
| TOTAL | $239,508 | $150,939 | $169,530 | $81,046 | $76,941 |
| Non-Current Assets | |||||
| PPE Net | 26,568 | 27,733 | 29,076 | 30,070 | 31,618 |
| Other Non-Current Assets | 34,242 | 34,976 | 36,158 | 36,869 | 37,551 |
| TOTAL | $60,810 | $62,709 | $65,234 | $66,939 | $69,169 |
| Total Assets | $300,318 | $213,648 | $234,764 | $147,985 | $146,110 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,406 | 7,436 | 4,223 | 8,368 | 8,111 |
| Accrued Expenses | 15,079 | 12,203 | 17,963 | 13,242 | 15,823 |
| Other current liabilities | 584 | 2,188 | 714 | 225 | 1,110 |
| TOTAL | $130,268 | $130,862 | $131,974 | $49,153 | $50,693 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 104,982 | 104,932 | 105,107 | 7,610 | 6,379 |
| Other Non-Current Liabilities | 38,793 | 39,863 | 40,903 | 41,964 | 42,968 |
| TOTAL | $40,554 | $41,394 | $42,387 | $43,915 | $44,403 |
| Total Liabilities | $170,822 | $172,256 | $174,361 | $93,068 | $95,096 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 180,213 | 154,409 | 154,068 | 153,136 | 153,034 |
| Common Shares | 180 | 154 | 154 | 153 | 153 |
| Retained earnings | -1,111,804 | -1,088,096 | -1,065,010 | -1,066,240 | -1,066,149 |
| Other shareholders' equity | 118 | 243 | 30 | 5 | 11 |
| TOTAL | $129,496 | $41,392 | $60,403 | $54,917 | $51,014 |
| Total Liabilities And Equity | $300,318 | $213,648 | $234,764 | $147,985 | $146,110 |